ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives

RECENT NEWS

ANI Pharmaceuticals to Present at Upcoming November Investor Conferences

2026-11-03

READ MORE >

ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET

2026-10-23

READ MORE >

NASDAQ - ANIP

$71.83

+ 1.17 (1.65%)

Pricing delayed by 20 minutes
Last updated 2026-11-03 15:45:00